Treating rheumatoid arthritis to target: Multinational recommendations assessment questionnaire

Boulos Haraoui, Josef S. Smolen, Daniel Aletaha, Ferdinand C. Breedveld, Gerd Burmester, Catalin Codreanu, José Pereira Da Silva, Maarten De Wit, Maxime Dougados, Patrick Durez, Paul Emery, João Eurico Fonseca, Allan Gibofsky, Juan Gomez-Reino, Winfried Graninger, Vedat Hamuryudan, Maria José Jannaut Peña, Joachim Kalden, Tore K. Kvien, Ieda LaurindoEmilio Martin-Mola, Carlomaurizio Montecucco, Pedro Santos Moreno, Karel Pavelka, Gyula Poor, Mario H. Cardiel, Ewa Stanislawska-Biernat, Tsutomu Takeuchi, Désirée Van Der Heijde, Adel Al Awadhi, Waleed Yousef AlShehhi, Durda Babic-Naglic, Beat A. Michel, Claudio Galarza-Maldonado, Mohammed Hammoudeh, Michael Harrison, Zlatimir Kolarov, Soo Kon Lee, Peter Nash, Kati Otsa, Tuulikki Sokka, Guillermo A. Tate, Matija Tomsic, Imad Uthman, Algirdas Venalis, Sol Villegas De Morales

Research output: Contribution to journalArticlepeer-review

70 Citations (Scopus)


Aim: To measure the level of agreement and application of 10 international recommendations for treating rheumatoid arthritis (RA) to a target of remission/low disease activity. Methods: A 10-point Likert scale (1=fully disagree, 10=fully agree) measured the level of agreement with each of 10 recommendations. A 4-point Likert scale (never, not very often, very often, always) assessed the degree to which each recommendation was being applied in current daily practice. If respondents answered 'never' or 'not very often', they were asked whether they would change their practice according to the particular recommendation. Results: A total of 1901 physicians representing 34 countries participated. Both agreement with and application of recommendations was high. With regard to application of recommendations in daily practice, the majority of responses were 'always' and 'very often'. A significant percentage of participants who were currently not applying these recommendations in clinical practice were willing to change their practice according to the recommendations. Conclusion: The results of this survey demonstrated great support of 'Treating RA to Target' recommendations among the international rheumatology community. Additional efforts may be needed to encourage application of the recommendations among certain clinicians who are resistant to changing their practice.

Original languageEnglish
Pages (from-to)1999-2002
Number of pages4
JournalAnnals of the rheumatic diseases
Issue number11
Publication statusPublished - 2011 Nov
Externally publishedYes

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Treating rheumatoid arthritis to target: Multinational recommendations assessment questionnaire'. Together they form a unique fingerprint.

Cite this